XNAS
CHRN
Market cap49mUSD
Sep 18, Last price
20.42USD
1D
1.44%
1Q
-12.47%
Jan 2017
-97.72%
IPO
-99.45%
Name
Ekso Bionics Holdings Inc
Chart & performance
P/E
—
P/S
3.87
EPS
—
Div yield, %
—
Shrs. gr., 5y
38.41%
Rev. gr., 5y
7.58%
Revenues
13m
-28.60%
Net income
-12m
L+3.22%
CFO
-12m
L+19.86%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
ChronoScale Corporation designs and develops a compute platform to support artificial intelligence (AI) workloads. The company focuses on large-scale deployments and provides dedicated compute environments engineered for performance, consistency, and long-term operational execution. The company is based in Dallas, Texas. ChronoScale Corporation operates as a subsidiary of Applied Digital Corporation.
Key people
Jack Peurach
President, Chief Executive Officer, Director · since 2018
william R Shaw
Chief Commercial Officer · since 2019
Marilyn Hamilton
Independent Director · since 2014
Charles Li
Independent Director · since 2018
Thomas A. Schreck
Independent Director · since 2018
Independent Director · since 2014
Headquarters & legal address
C/O Incorp Services, Inc.
2360 Corporate Circle
Suite 400
Henderson, NV 89074-7722
US
2360 Corporate Circle
Suite 400
Henderson, NV 89074-7722
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||